Best of all, it has very
low chances of side effects, and it is extremely cost effective.
Not exact matches
Companies like U.S. biotech giant Gilead and the U.K.'s GlaxoSmithKline (the majority stakeholder in global HIV partnership ViiV Healthcare) have developed drugs that drastically
lower the
chance of HIV infection — or which simply
lower the number
of drugs you have to take to treat it, consequently curbing the risk
of toxic
side effects while simplifying medical regimens.
This allows you to take a
lower dosage
of painkillers and halve your
chances of experiencing any
of their associated
side effects, or even an adverse reaction.
With safe, natural approaches, there is a
lower risk
of side effects and a higher
chance of successful, lasting outcomes.
Unfortunately, the
chances of obtaining a second remission are
lower and the risk
of side effects may be higher.
We get the best
of both worlds in this case because the
low amount
of medication means less
chance for
side effects when used long term.